Literature DB >> 10851293

Cryosurgical Modeling: Sequence of Freezing and Cytotoxic Agent Application Affects Cell Death.

.   

Abstract

Cryosurgery is now being used to eradicate a variety of tumors, including those that are found in the kidney. Because it is well known that cancer treatments are often most effective when combined with adjunctive therapies, we developed a model kidney cell culture system to determine: (1) if 5-fluorouracil (5-FU), a compound known to be a poor kidney tumor chemotherapeutic agent, can be more effective when combined with cryosurgery; and (2) how kidney cells die through freezing-induced injury that might occur during cryosurgery. The DNA isolated from kidney cells that died during an exposure to -15 degrees C showed nonrandom cleavage when separated on an agarose gel, indicating that cell death was attributable, in part, to apoptosis, whereas DNA isolated from kidney cells that died during exposure to -75 degrees C showed random cleavage, indicating that cell death was attributable, in part, to necrosis. The apoptotic protease inhibitor, caspase 1 inhibitor V, was able to prevent freezing-induced cell death, supporting the idea that apoptosis may be a mechanism of cell death in the periphery of the iceball created by cryosurgical procedures in vivo. Because 5-FU is known to induce apoptosis, this drug was used in combination with various freezing regimes to determine if the combination might be a better method of killing cells than either treatment alone. Whereas the addition of 5-FU at the same time or 2 days after freezing resulted in a synergistic lethal effect, many cells survived this combination treatment. When cells were treated with 5-FU 2 days prior to freezing, however, there was an apparent complete loss of viability. The reason may be that, by an unknown mechanism, freezing enhances the ability of 5-FU-treated cells to move more effectively through the apoptosis pathway. Kidney tumors may have robust antiapoptotic mechanisms that make them refractory to 5-FU, but these mechanisms might be overridden by freezing. In either case, the data suggest that chemotherapy may be more effective when followed by cryosurgery.

Entities:  

Year:  1999        PMID: 10851293

Source DB:  PubMed          Journal:  Mol Urol        ISSN: 1091-5362


  5 in total

1.  Use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model.

Authors:  K L Santucci; K K Snyder; J M Baust; R G Van Buskirk; V Mouraviev; T J Polascik; A A Gage; J G Baust
Journal:  Prostate Cancer Prostatic Dis       Date:  2011-01-11       Impact factor: 5.554

2.  An In Vitro Investigation into Cryoablation and Adjunctive Cryoablation/Chemotherapy Combination Therapy for the Treatment of Pancreatic Cancer Using the PANC-1 Cell Line.

Authors:  John M Baust; Kimberly L Santucci; Robert G Van Buskirk; Isaac Raijman; William E Fisher; John G Baust; Kristi K Snyder
Journal:  Biomedicines       Date:  2022-02-15

3.  Optimisation and molecular signalling of apoptosis in sequential cryotherapy and chemotherapy combination in human A549 lung cancer xenografts in SCID mice.

Authors:  V Forest; R Hadjeres; R Bertrand; R Jean-François
Journal:  Br J Cancer       Date:  2009-05-19       Impact factor: 7.640

4.  Cryoablation for small renal masses.

Authors:  J L Dominguez-Escrig; K Sahadevan; P Johnson
Journal:  Adv Urol       Date:  2008

5.  Dose Escalation of Vitamin D3 Yields Similar Cryosurgical Outcome to Single Dose Exposure in a Prostate Cancer Model.

Authors:  Kimberly L Santucci; John M Baust; Kristi K Snyder; Robert G Van Buskirk; John G Baust
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.